Golden House Ltd (TLV:GOHO)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,055.00
-22.00 (-2.04%)
Sep 10, 2026, 5:24 PM IDT
Golden House Market Cap
Golden House has a market cap or net worth of 167.11 million as of September 11, 2026. Its market cap has decreased by -14.05% in one year.
Market Cap
167.11M
Enterprise Value
126.22M
Revenue
52.70M
Ranking
n/a
PE Ratio
17.06
Stock Price
1,055.00
ChartMarket Cap Chart
Since March 30, 2006, Golden House's market cap has increased from 74.77M to 167.11M, an increase of 123.50%. That is a compound annual growth rate of 4.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 167.11M | 5.38% |
| Dec 31, 2025 | 158.58M | -55.97% |
| Dec 31, 2024 | 360.14M | 47.35% |
| Dec 31, 2023 | 244.41M | 50.96% |
| Dec 29, 2022 | 161.90M | -36.51% |
| Dec 30, 2021 | 255.00M | 16.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 130.98B |
| Danel (Adir Yeoshua) | 2.54B |
| Amal Holdings A.D. | 2.09B |
| BrainsWay | 1.71B |
| Bonus BioGroup | 202.09M |
| InterCure | 191.19M |
| Rekah Pharmaceutical Industry | 129.90M |
| Epitomee Medical | 119.71M |